Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference48 articles.
1. Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients;Ahmed;J. Surg. Oncol.,1986
2. Relation between the EBV and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination;Anderson-Anvret;Int. J. Cancer,1977
3. A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma;Au;Ann. Oncol.,1994
4. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type;Azli;Eur. J. Cancer,1992
5. Final report of Phase II study of chemotherapy with bleomycin, epirubicin and cisplatin for locally advanced and metastatic recurrent;Azli;Cancer J. Sci. Am.,1995
Cited by 177 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes;Molecular Cancer;2024-01-22
2. Evaluation of Three-Year Overall and Disease-Free Survival in Iranian Patients with Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy (IMRT): A Historical Cohort Single Center Study;International Journal of Cancer Management;2023-06-11
3. Cisplatin-docetaxel induction chemotherapy for patients with nasopharyngeal carcinoma in a non-endemic cohort;Journal of Chemotherapy;2023-05-21
4. Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma;Cancer Biomarkers;2023-05-15
5. Chemotherapy for Locoregionally Advanced NPC;Medical Radiology;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3